Walgreens Boots Alliance (NASDAQ:WBA) Posts Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) announced its quarterly earnings data on Tuesday. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10, Zacks reports. The firm had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.20 EPS.

Walgreens Boots Alliance Trading Up 0.8 %

Shares of Walgreens Boots Alliance stock traded up $0.09 on Friday, hitting $10.78. The stock had a trading volume of 12,267,104 shares, compared to its average volume of 20,990,767. The stock has a 50 day moving average of $10.75 and a 200 day moving average of $10.07. The firm has a market capitalization of $9.32 billion, a P/E ratio of -1.05, a PEG ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance has a twelve month low of $8.08 and a twelve month high of $18.83. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Analyst Upgrades and Downgrades

Several equities analysts have commented on WBA shares. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Royal Bank of Canada raised their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. StockNews.com started coverage on Walgreens Boots Alliance in a report on Friday. They set a "hold" rating for the company. Finally, Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.